U.S. drug regulators approved Botox from Allergan for treating a specific type of urinary incontinence on Wednesday.
The U.S. Food and Drug Administration said Botox—made popular as a treatment for smoothing facial wrinkles—can also be injected into the bladder to treat people who lose bladder control because of neurologic conditions such as spinal cord injury.
Shares of Allergan rose 2.2 percent to $77.28 in trading on the New York Stock Exchange.
(Reporting by Anna Yukhananov, additional reporting by Bill Berkrot; editing by Derek Caney)
###
(Reuters)